ClinicalTrials.gg
Not yet recruitingNCT07883707Updated Oct 20, 2026

Parent-Facilitated Early Oral-Sensory Experience in the NICU for Feeding Outcomes

An interventional study of Parent-Facilitated Early Oral-Sensory Experience (PEOE) in Premature Birth, Infant, Premature and Infant, Very Premature, sponsored by Boston College. Not yet recruiting. Open to participants aged 0 Days to 32 Weeks. Per ClinicalTrials.gov, last updated 2026-10-20.

Sponsored by Boston College · Not applicable, Interventional, and Supportive care

Updated Oct 20, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Non-randomized
Ages
0 Days to 32 Weeks
Sex
All
01

Study summary

The purpose of this study is to evaluate the feasibility, acceptability, and preliminary effects of the Parent-Facilitated Early Oral-Sensory Experience (PEOE) program for very preterm infants in the Neonatal Intensive Care Unit (NICU). Very preterm infants (born before 32 weeks gestational age) often face challenges developing oral feeding skills. The PEOE intervention involves training parents to deliver gentle, synchronized oral-sensory stimulation-such as placing small droplets of human milk in the infant's mouth paired with gentle touch, voice, and scent-starting immediately before gavage feedings and potentially continuing into the feeding. This study uses a sequential two-group design. The first group of parents and infants will receive usual NICU care. The second group will receive the PEOE intervention. Researchers will measure how feasible and acceptable the program is for parents and staff, infant physiological responses, feeding skill development, length of hospital stay, and parental emotional well-being.

02

Conditions studied

  • Premature Birth
  • Infant, Premature
  • Infant, Very Premature

Browse trials for

Keywords

  • Oral-Sensory Experience
  • Early Oral Feeding
  • Neonatal Intensive Care Unit (NICU)
  • Parent-Delivered Intervention
  • Multisensory Stimulation
  • Mother's Milk / Human Milk
  • Family-Centered Care
  • Very Preterm Infant
  • Gavage Feeding
  • Premature Infant Feeding
03

In context

Premature Birth

2,610 studies on the registry are indexed under Premature Birth; 507 are open to participants now.

This study's planned enrollment of 60 is below the median of 84 across 1,722 interventional studies indexed under Premature Birth.

Browse Premature Birth studies →

Lead sponsor

Boston College is the lead sponsor of 38 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
0 Days to 32 Weeks
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Very preterm infants born at less than 32 weeks gestational age

  • Admitted to the Beth Israel Deaconess Medical Center (BIDMC) Neonatal Intensive Care Unit (NICU)
  • Commenced or scheduled to commence enteral feedings
  • Parent or legal guardian of an eligible infant
  • Parent age 18 years or older
  • Parent literate in English, Spanish, or Portuguese
  • Parent available to participate in study data collection and/or intervention sessions

Exclusion criteria

Exclusion Criteria:

  • Born at 32 weeks gestational age or greater
  • Presence of major congenital malformations of the mouth, face, or gastrointestinal tract
  • Serious comorbidities that interfere with normal oral feeding development
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Sequential assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • No intervention
    Usual Care

    Parent-infant dyads receiving standard NICU care and standard enteral feeding without structured oral-sensory stimulation.

  • Experimental
    PEOE Intervention

    Parent-infant dyads receiving up to five individualized coaching sessions with a trained interventionist. Parents deliver the Parent-Facilitated Early Oral-Sensory Experience (PEOE) intervention independently during NICU visits up to four times daily before and/or during gavage feedings until oral feeding initiation.

    Behavioral: Parent-Facilitated Early Oral-Sensory Experience (PEOE)

Interventions

  • BehavioralParent-Facilitated Early Oral-Sensory Experience (PEOE)

    Parents administer small droplets of human milk (expressed breast milk or donor milk, up to 1 mL) orally via syringe, guided by infant readiness cues (e.g., mouthing, rooting). This is paired with synchronized multisensory stimulation (gentle touch, parental voice, parental scent, and taste/smell of milk). Sessions start immediately before gavage feedings and may continue into the feeding. Sessions occur in the incubator or during skin-to-skin care up to four times daily.

06

What researchers measure

Primary outcomes

  1. Study Feasibility and Acceptability Rates

    Composite measure of study feasibility evaluated by overall eligibility rate, recruitment rate, enrollment rate, retention rate, and intervention protocol completion rate.

    Time frame: From screening through NICU discharge (up to 6 weeks after enrollment).

  2. Infant Short-Term Heart Rate Response Across Intervention Sessions

    Change in mean heart rate in beats per minute (bpm) and variability (coefficient of variation) measured from pre-feeding baseline (30 minutes prior) to during the PEOE intervention session and 30 minutes post-intervention.

    Time frame: Weekly from the first week of enteral feeding through oral feeding initiation (up to 6 weeks post-enrollment)

  3. Infant Short-Term Respiratory Rate Response Across Intervention Sessions

    Change in mean respiratory rate (breaths per minute) and variability (coefficient of variation) measured from pre-feeding baseline (30 minutes prior) to during the PEOE intervention session and 30 minutes post-intervention.

    Time frame: Weekly from the first week of enteral feeding through oral feeding initiation (up to 6 weeks post-enrollment)

  4. Infant Short-Term Oxygen Saturation Response Across Intervention Sessions

    Change in mean oxygen saturation (SpO2) percentage and variability (coefficient of variation) measured from pre-feeding baseline (30 minutes prior) to during the PEOE intervention session and 30 minutes post-intervention.

    Time frame: Weekly from the first week of enteral feeding through oral feeding initiation (up to 6 weeks post-enrollment)

  5. Infant Short-Term Heart Rate Variability (High-Frequency HRV) Across PEOE Intervention Sessions

    Change in high-frequency heart rate variability (HF-HRV in ms2) measured from pre-feeding baseline (30 minutes prior) to during the PEOE intervention session and 30 minutes post-intervention.

    Time frame: Weekly from the first week of enteral feeding through oral feeding initiation (up to 6 weeks post-enrollment)

  6. Infant Short-Term Heart Rate Variability (SD12 Ratio) Across Intervention Sessions

    Change in Poincare nonlinear ratio (SD12) measured from pre-feeding baseline (30 minutes prior) to during the PEOE intervention session and 30 minutes post-intervention.

    Time frame: Weekly from the first week of enteral feeding through oral feeding initiation (up to 6 weeks post-enrollment)

  7. Infant Heart Rate Response During Feeding Near Discharge

    Change in mean heart rate (bpm) and variability (coefficient of variation) measured from 30 minutes pre-feeding baseline to during feeding and 30 minutes post-feeding.

    Time frame: Assessed during a single feeding observation during the discharge week (approximately 2 to 6 weeks post-enrollment)

  8. Infant Respiratory Rate Response During Feeding Near Discharge

    Change in mean respiratory rate (breaths per minute) and variability (coefficient of variation) measured from 30 minutes pre-feeding baseline to during feeding and 30 minutes post-feeding.

    Time frame: Assessed during a single feeding observation during the discharge week (approximately 2 to 6 weeks post-enrollment)

  9. Infant Oxygen Saturation Response During Feeding Near Discharge

    Change in mean oxygen saturation (SpO2) percentage and variability (coefficient of variation) measured from 30 minutes pre-feeding baseline to during feeding and 30 minutes post-feeding.

    Time frame: Assessed during a single feeding observation during the discharge week (approximately 2 to 6 weeks post-enrollment)

  10. Infant Heart Rate Variability (High-Frequency HRV) During Feeding Near Discharge

    Change in high-frequency heart rate variability (HF-HRV in ms2) measured from 30 minutes pre-feeding baseline to during feeding and 30 minutes post-feeding.

    Time frame: Assessed during a single feeding observation during the discharge week (approximately 2 to 6 weeks post-enrollment).

  11. Infant Heart Rate Variability (SD12 Ratio) During Feeding Near Discharge

    Change in Poincare nonlinear ratio (SD12) measured from 30 minutes pre-feeding baseline to during feeding and 30 minutes post-feeding.

    Time frame: Assessed during a single feeding observation during the discharge week (approximately 2 to 6 weeks post-enrollment).

  12. Infant Splanchnic-to-Cerebral Oxygenation Ratio Pre- to Post-Feeding Near Discharge

    Change in splanchnic-to-cerebral oxygen ratio (SOCR) measured via near-infrared spectroscopy (NIRS) from 30 minutes pre-feeding baseline to during feeding and 30 minutes post-feeding.

    Time frame: Assessed during a single feeding observation during the discharge week (approximately 2 to 6 weeks post-enrollment).

  13. Infant Behavioral Feeding Regulation Near Discharge

    Infant overall behavioral feeding skill evaluated during a single discharge feeding observation using the Early Feeding Skills (EFS) assessment tool total score (score range 19-57, higher scores indicate greater feeding skill and regulation).

    Time frame: Assessed during a single feeding observation during the discharge week (approximately 2 to 6 weeks post-enrollment)

  14. Parental Depressive Symptoms Score

    Parental depressive symptoms assessed using the Edinburgh Postnatal Depression Scale (EPDS) total score (range 0-30, higher scores indicate greater depressive symptoms).

    Time frame: At enrollment, every 2 weeks during NICU hospitalization, and at NICU discharge (up to 6 weeks post-enrollment)

  15. Parental Anxiety State Score

    Parental anxiety symptoms assessed using the State-Trait Anxiety Inventory-Short Form (STAI-SF) total score (range 20-80, higher scores indicate higher anxiety).

    Time frame: At enrollment, every 2 weeks during NICU hospitalization, and at NICU discharge (up to 6 weeks post-enrollment)

  16. Parental NICU Stress Score

    Parental stress resulting from the NICU environment assessed using the Parental Stressor Scale: NICU (PSS:NICU) total metric score (range 1-5, higher scores indicate greater stress).

    Time frame: At enrollment, every 2 weeks during NICU hospitalization, and at NICU discharge (up to 6 weeks post-enrollment)

  17. Parenting Self-Efficacy

    Task-specific parenting confidence score evaluated using the Karitane Parenting Confidence Scale (KPCS; score range 0 to 45, with higher scores indicating greater confidence).

    Time frame: At enrollment and at discharge (up to 6 weeks post-enrollment)

Secondary outcomes

  1. Parent Feeding Co-Regulation Skill Score

    Parent responsive feeding co-regulation capability assessed via videotaped discharge feeding observations using the Dynamic-Early Feeding Skills (D-EFS) Caregiver Feeding Action subscale. Calculated as the percentage of total feeding duration that the parent spends engaged in responsive co-regulation behaviors (range 0% to 100% of feeding time, where a higher percentage indicates greater parent co-regulatory skill and responsiveness).

    Time frame: Assessed during a single feeding observation during the discharge week (approximately 2 to 6 weeks post-enrollment)

  2. Length of NICU Hospital Stay

    Total length of hospital stay measured in cumulative days from infant birth through final NICU discharge (extracted from electronic health records).

    Time frame: From enrollment through NICU discharge (up to 8 weeks post-enrollment)

  3. Time to Achieve Full Oral Feeding

    Number of days required from study enrollment for the infant to achieve full oral feeding, defined as consuming 100% of daily enteral nutrition by mouth for at least 48 consecutive hours (extracted from electronic health records).

    Time frame: From enrollment through NICU discharge (up to 8 weeks post-enrollment)

  4. Infant Weight Gain Velocity

    Average infant weight gain velocity calculated in grams per kilogram per day (g/kg/day) from baseline enrollment to NICU discharge (extracted from electronic health records).

    Time frame: From enrollment through NICU discharge (up to 8 weeks post-enrollment)

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for May 2028, 18 months later.

Of 753 non-industry interventional studies with no phase under Premature Birth, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 47. This study's planned 18 months is below that.

Counting every sponsor, half of 775 studies reached it within 24 months; a quarter within 12 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 1, 2026
First posted
Oct 20, 2026
StartEst.
Nov 1, 2026
Primary completionEst.
May 31, 2028
CompletionEst.
Sep 30, 2028
Last update
Oct 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 20, 2026
Show all 1 update
  1. Oct 20, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07883707
Lead sponsor
Boston College
Responsible party
Sponsor
First posted
Oct 20, 2026
Start date
Nov 1, 2026 (estimated)
Primary completion
May 31, 2028 (estimated)
Completion
Sep 30, 2028 (estimated)
Last update
Oct 20, 2026

Study contacts

Jinhee Park, PhD, RN, FAAN
Contact
jinhee.park@bc.edu
617-552-6542
Rachel Copertino, DNP, NNP-BC, IBCLC
Contact
rcoperti@bidmc.harvard.edu
Jinhee Park, PhD, RN, FAAN
principal investigator · Boston College

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion